Abstract:Objective To explore the association between multidrug resistance 1gene (MDR1)polymorphisms with the therapeutic efficacy of paliperidone (9-hydroxyrisperidone) and risperidone in Han Chinese schizophrenic patients. Methods One hundred and thirty-three schizophrenic patients were given paliperidone or risperidone LAI for a 12-week treatment. The PANSS was used to assess the main therapeutic efficacy, and the Clinical Global Impression-Severity (CGI-S) scale and the Personal and Social Function scale (PSP) were used to as the secondary therapeutic efficacy assessments. The patients were evaluated every 2 weeks. The polymerase chain reaction-based-restriction fragment length polymorphisms (PCRRFLP) and DNA sequencing were used to detect the genotypes of 5 candidate single nucleotide polymorphisms (SNPs). The association between MDR1 genotypes with the therapeutic efficacy was analyzed using the chi-square and ANOVA tests. Results There were no statistical significant differences between MDR1 gene polymorphism and the PANSS reduction rate or clinical efficacy rate(P ＞0.05). Non-parameter tests revealed that, patients carrying CC genotype of locus rs1045642 had better efficacy in negative symptom item ' difficulty in abstract thinking' ( Z = - 2. 62, P = 0. 009 ) and positive symptom item ' grandiosity '(Z = -2. 84,P =0. 005), and GG genotype of locus rs2032582 carriers had worse improvements in general psychopathology item 'tension' (Z = -2.50,P =0. 012), and as to patient who carried A allele of locus rs1202169 had better improvements in general psychopathology item 'active societal avoidance'(Z = -2. 09,P =0. 036), and CC genotype of locus rs13233308 carriers had worse improvements in items ' guilt feelings' (Z = - 2. 09, P = 0. 036) and ' lack of spontaneity and flow of conversation' (Z = - 2.73,P = 0. 006) ,TT genotype carriers had a better improvement in item ' tension' ( Z = - 2. 54, P = 0. 011).Secondary clinical efficacy analysis showed that locus C allele of rs1045642 might be associated with patients' higher PSP score (Z = -2. 18, P = 0. 029). Conclusion MDR1 gene polymorphisms may be not associated with the therapeutic efficacy of paliperidone and risperidone in Han Chinese schizophrenic patients, but may influence the clinical improvements of 'delusion' or 'active societal avoidance' of schizophrenia, which maybe provide references for schizophrenic patients' individual drug therapy.

Association of dopamine D3 receptor gene functional polymorphism with response to antipsychotics in first-episode schizophrenic patients

Pharmacogenetics of Treatment in First-Episode Schizophrenia: D3 and 5-HT2C Receptor Polymorphisms Separately Associate with Positive and Negative Symptom Response

The Relationship Between Drd2 Gene Polymorphisms (c957t and C939t) and Schizophrenia: A Meta-Analysis

Association study of dopamine D3 receptor gene with schizophrenia subtypes

Effects of the Dopamine D3 Receptor (DRD3) Gene Polymorphisms on Risperidone Response: a Pharmacogenetic Study.

The Relationship Between the Therapeutic Response to Risperidone and the Dopamine D(2) Receptor Polymorphism in Chinese Schizophrenia Patients

Association of Dopamine Receptor D1 (DRD1) Polymorphisms with Risperidone Treatment Response in Chinese Schizophrenia Patients.

DRD3 Ser9Gly polymorphism and treatment response to antipsychotics in schizophrenia: A meta-analysis

COMT, 5-HTR2A, and SLC6A4 Mrna Expressions in First-Episode Antipsychotic-Naïve Schizophrenia and Association with Treatment Outcomes

Association Between a Polymorphism of the HTR3A Gene and Therapeutic Response to Risperidone Treatment in Drug-Naive Chinese Schizophrenia Patients

Response To Chlorpromazine Treatment May Be Associated With Polymorphisms Of The Drd2 Gene In Chinese Schizophrenic Patients

Association of multidrug resistance 1 gene polymorphism with the clinical efficacy of paliperidone and risperidone in schizophrenic patients

Dopamine Transporter Polymorphisms and Risperidone Response in Chinese Schizophrenia Patients: an Association Study.

The Ser9gly Polymorphism of the Dopamine D3 Receptor Gene and Risk of Schizophrenia: an Association Study and A Large Meta-Analysis

Relationship of Antipsychotic Drug-Induced Weight Gain with the Polymorphism of Dopamine D2 Receptor Gene and Treatment Response in Schizophrenic Patients

Relationship Between MDR1 Gene Polymorphisms and Therapeutic Response to Risperidone in Schizophrenic Patients

Association between dopamine receptor gene polymorphisms and effects of risperidone treatment: A systematic review and meta-analysis.

Association of DRD2 Polymorphisms and Chlorpromazine-Induced Extrapyramidal Syndrome in Chinese Schizophrenic Patients1

Disequilibrium transmission of the Ser9Gly polymorpphism of the dopamine D3 receptor gene in 151 Chinese pedigrees

Association Between A-241G Polymorphism of Dopamine D_2 Receptor Promoter Gene and Schizophrenia in Chinese

Association Study of Dopamine Receptor Genes Polymorphisms with the Risk of Schizophrenia in the Han Chinese Population